5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting

NCT00834587 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 5 mg/500 mg METAGLIP™ Tablets
DRUG: 5 mg/500 mg Glipizide Metformin Hydrochloride Tablets

Sponsor

Teva Pharmaceuticals USA